SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for EQUIFAX INC (EFX) (CIK 0000033185) (EFX) — Oct 31, 2024

EQUIFAX INC (EFX) (CIK 0000033185)
Date: Oct. 31, 2024 · CIK: 0000033185 · Accession: 0000000000-24-012154

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-06605

Date
October 31, 2024
Author
John W. Gamble, Jr
Form
UPLOAD
Company
EQUIFAX INC (EFX) (CIK 0000033185)

Letter

October 31, 2024 John W. Gamble, Jr Chief Financial Officer Equifax Inc. 1550 Peachtree Street, N.W. Atlanta, GA 30309 Re:Equifax Inc. Form 10-K for the Fiscal Year Ended December 31, 2023 File No. 001-06605 Dear John W. Gamble Jr: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc:John Kelly

Show Raw Text
October 31, 2024
John W. Gamble, Jr
Chief Financial Officer
Equifax Inc.
1550 Peachtree Street, N.W.
Atlanta, GA 30309
Re:Equifax Inc.
Form 10-K for the Fiscal Year Ended December 31, 2023
File No. 001-06605
Dear John W. Gamble Jr:
            We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:John Kelly